Potentially “life-threatening” labeling mix-up prompts recall of blood pressure medication

News
hydrochlorothiazide

A potentially “life-threatening” labeling mix-up spurring a nationwide recall of high blood pressure medication. 

The Food and Drug Administration (FDA) announced Accord Healthcare is voluntarily recalling a single lot of its 12.5 milligram hydrochlorothiazide tablets.

This happened after a pharmacy reported finding a one-hundred count bottle that actually contained another medication. 

Accord is recalling the rest of that lot due to the potential mix-up of labeling. 

The FDA says both drugs can be used to treat high blood pressure but spironolactone causes the body to flush out excess water and sodium and store potassium. 

Patients who mistakenly take it could experience elevated potassium levels as a result. 

No patients have reported ill effects in connection with the recall. 

Those who are prescribed the accord medication, should make sure their pills are a light orange color with a letter “h” on one side and a number “1” on the other. 

Consumers are urged to report any drugs that do not match that description to their pharmacist.
 

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest News Video

Trending Stories